At the time of writing, Evolent Health Inc [EVH] stock is trading at $19.58, down -2.10%. An important factor to consider is whether the stock is rising or falling in short-term value. The EVH shares have gain 2.41% over the last week, with a monthly amount drifted -14.87%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Evolent Health Inc [NYSE: EVH] stock has seen the most recent analyst activity on April 22, 2024, when Citigroup initiated its Buy rating and assigned the stock a price target of $40. Previously, Oppenheimer started tracking the stock with Outperform rating on March 01, 2024, and set its price target to $45. On January 03, 2024, Barclays initiated with a Overweight rating and assigned a price target of $39 on the stock. JMP Securities started tracking the stock assigning a Mkt Outperform rating and suggested a price target of $37 on December 06, 2023. UBS initiated its recommendation with a Buy and recommended $46 as its price target on October 16, 2023. Stephens started tracking with a Overweight rating for this stock on April 12, 2023, and assigned it a price target of $40. In a note dated November 01, 2022, Truist initiated an Hold rating and provided a target price of $33 on this stock.
For the past year, the stock price of Evolent Health Inc fluctuated between $17.98 and $35.00. Currently, Wall Street analysts expect the stock to reach $43 within the next 12 months. Evolent Health Inc [NYSE: EVH] shares were valued at $19.58 at the most recent close of the market. An investor can expect a potential return of 119.61% based on the average EVH price forecast.
Analyzing the EVH fundamentals
According to Evolent Health Inc [NYSE:EVH], the company’s sales were 2.18B for trailing twelve months, which represents an 49.56% jump. Gross Profit Margin for this corporation currently stands at 0.19% with Operating Profit Margin at -0.03%, Pretax Profit Margin comes in at -0.06%, and Net Profit Margin reading is -0.05%. To continue investigating profitability, this company’s Return on Assets is posted at -0.04, Equity is -0.1 and Total Capital is -0.03. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.76.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 19.16 points at the first support level, and at 18.74 for the second support level. However, for the 1st resistance point, the stock is sitting at 20.09, and for the 2nd resistance point, it is at 20.60.
Ratios To Look Out For
It is important to note that Evolent Health Inc [NYSE:EVH] has a current ratio of 1.02. On the other hand, the Quick Ratio is 1.02, and the Cash Ratio is 0.33. Considering the valuation of this stock, the price to sales ratio is 1.05, the price to book ratio is 2.14.
Transactions by insiders
Recent insider trading involved Blackley Seth, Chief Executive Officer, that happened on Dec 05 ’23 when 0.14 million shares were sold. PRESIDENT, McCarthy Daniel Joseph completed a deal on Nov 15 ’23 to sell 11000.0 shares. Meanwhile, Chief Operating Officer Rafferty Emily Ann sold 7900.0 shares on Aug 15 ’23.
